The ACCP "Excellence in Achievement" Program is pleased to recognize Mohamed-Eslam Mohamed, RPh, PhD, FCP, Director of Clinical Pharmacology & Pharmacometrics at AbbVie Inc. He earned his PhD in Clinical Pharmaceutical Sciences from the Univ of Florida Coll of Pharmacy in 2010 where he also completed a postdoctoral fellowship. Dr. Mohamed earned his Bachelor’s degree in Pharmacy from Ain Shams Univ in Cairo, Egypt. He has been working at AbbVie Inc since 2013 where he supports the development of new drugs for the treatment of autoimmune disorders, including rheumatologic, gastrointestinal and dermatologic diseases. Dr. Mohamed has co-authored over 40 manuscripts and 35 meeting abstracts spanning the fields of clinical pharmacology, immunology, drug metabolism and pharmacogenomics and has served as a speaker at national and international congresses. Through his work at AbbVie Inc, Dr. Mohamed has been named as a co-inventor on two patents for the development of treatments for autoimmune diseases and has received several highly prestigious awards from AbbVie leadership in recognition of the impact of his contributions to drug development.
Dr. Mohamed is a Fellow of the American College of Clinical Pharmacology® (ACCP). He has contributed to the success of ACCP through serving on committees, participating as a Faculty Speaker as well as a Poster Presenter at several ACCP Annual Meetings and publishing manuscripts in ACCP journals. During his term in the Public Policy Committee, Dr. Mohamed co-authored the ACCP position paper on "Inclusion of Adolescents With Adults in Phase 3 Clinical Trials: Overview of the Current State and a Call for Action", which was published in The Journal of Clinical Pharmacology in March 2020. He is currently serving as a member of the ACCP Honors & Awards Committee and Co-chaired two symposia at the 2021 ACCP Virtual Annual Meeting. Dr. Mohamed is also a Courtesy Clinical Assistant Professor at the Univ of Florida Coll of Pharmacy where he serves as a career mentor for PharmD students. He is also currently serving on the Innovation & Quality Consortium COVID-19 working group and as an industry expert in the ICH M13 guidance support team.
Dr. Mohamed kindly shared his thoughts on what ACCP membership means to him:
"When I think of my ACCP membership, what comes to my mind is the opportunity to engage with some of the brightest minds in our field to have an impact that drives the clinical pharmacology field forward. Our networks, communications and collaborations today are what define the clinical pharmacology field in the next 10 years. Being a Member of ACCP provides this gratifying opportunity to have a role in shaping the future of clinical pharmacology and how it impacts drug development and patients’ lives. I am delighted to say that ACCP has played a critical role in my professional development through the opportunities it provides to volunteer in the different committees and activities. I am very grateful to ACCP and look forward to continuing to actively support the organization."
Congratulations, Dr. Mohamed, on being recognized for your outstanding achievements and contributions to ACCP!